1. Home
  2. SCYX vs SELX Comparison

SCYX vs SELX Comparison

Compare SCYX & SELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • SELX
  • Stock Information
  • Founded
  • SCYX 1999
  • SELX 2021
  • Country
  • SCYX United States
  • SELX Taiwan
  • Employees
  • SCYX N/A
  • SELX N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • SELX
  • Sector
  • SCYX Health Care
  • SELX
  • Exchange
  • SCYX Nasdaq
  • SELX Nasdaq
  • Market Cap
  • SCYX 34.9M
  • SELX 41.2M
  • IPO Year
  • SCYX 2014
  • SELX N/A
  • Fundamental
  • Price
  • SCYX $0.83
  • SELX $1.08
  • Analyst Decision
  • SCYX
  • SELX
  • Analyst Count
  • SCYX 0
  • SELX 0
  • Target Price
  • SCYX N/A
  • SELX N/A
  • AVG Volume (30 Days)
  • SCYX 167.5K
  • SELX 8.8K
  • Earning Date
  • SCYX 08-13-2025
  • SELX 01-01-0001
  • Dividend Yield
  • SCYX N/A
  • SELX N/A
  • EPS Growth
  • SCYX N/A
  • SELX N/A
  • EPS
  • SCYX N/A
  • SELX N/A
  • Revenue
  • SCYX $3,257,000.00
  • SELX $1,040,571.00
  • Revenue This Year
  • SCYX $422.61
  • SELX N/A
  • Revenue Next Year
  • SCYX $240.56
  • SELX N/A
  • P/E Ratio
  • SCYX N/A
  • SELX N/A
  • Revenue Growth
  • SCYX N/A
  • SELX N/A
  • 52 Week Low
  • SCYX $0.66
  • SELX $0.85
  • 52 Week High
  • SCYX $1.66
  • SELX $1.87
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 54.46
  • SELX 53.08
  • Support Level
  • SCYX $0.82
  • SELX $1.01
  • Resistance Level
  • SCYX $0.88
  • SELX $1.13
  • Average True Range (ATR)
  • SCYX 0.04
  • SELX 0.09
  • MACD
  • SCYX -0.00
  • SELX 0.02
  • Stochastic Oscillator
  • SCYX 48.45
  • SELX 66.20

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

Share on Social Networks: